Revenue ($USD) : $1,201,942,000
R&D spend : $98,524,000.00
Employees : 3,000
Fiscal year end : 12/31/22
CEO : Chris Barry

NuVasive recently reported mixed Q2 results ahead of its planned merger with Globus Medical. As of the writing of this description in early August, officials at both companies were sticking by plans to complete the deal — even as the Federal Trade Commission continues to scrutinize the merger. Combining NuVasive and Globus Medical would create the second-largest spine tech company in the world behind Medtronic. –CN